Ligand-based design, in silico ADME-Tox filtering, synthesis and biological evaluation to discover new soluble 1,4-DHP-based CFTR activators

Sonja Visentin; Giuseppe Ermondi; Claudio Medana; Nicoletta Pedemonte; Luis Galietta; Giulia Caron

doi:10.1016/j.ejmech.2012.07.017

Ligand-based design, in silico ADME-Tox filtering, synthesis and biological evaluation to discover new soluble 1,4-DHP-based CFTR activators

Sonja Visentin, Giuseppe Ermondi, Claudio Medana, Nicoletta Pedemonte, Luis Galietta, Giulia Caron

Istituto "Giannina Gaslini"

Research output: Contribution to journal › Article

Abstract

The altered gating of the mutant CFTR chloride channel cystic fibrosis (CF) may be corrected by small molecules called potentiators. We present a molecular scale simulation system for the discovery of ΔF508-CFTR soluble potentiators. Results report the design, ADME-Tox prediction, synthesis, solubility determination and in vitro biological evaluation of two 1,4-dihydropyridines (DHPs). Compound 1 shows a promising ADME-Tox profile and good potency.

Original language	English
Pages (from-to)	188-194
Number of pages	7
Journal	European Journal of Medicinal Chemistry
Volume	55
DOIs	https://doi.org/10.1016/j.ejmech.2012.07.017
Publication status	Published - Sep 2012

Fingerprint

Keywords

3D-QSAR
ADME-Tox
CFTR potentiators
DHP
GRIND
VolSurf+

ASJC Scopus subject areas

Drug Discovery
Organic Chemistry
Pharmacology

Cite this

Visentin, S., Ermondi, G., Medana, C., Pedemonte, N., Galietta, L., & Caron, G. (2012). Ligand-based design, in silico ADME-Tox filtering, synthesis and biological evaluation to discover new soluble 1,4-DHP-based CFTR activators. European Journal of Medicinal Chemistry, 55, 188-194. https://doi.org/10.1016/j.ejmech.2012.07.017

Ligand-based design, in silico ADME-Tox filtering, synthesis and biological evaluation to discover new soluble 1,4-DHP-based CFTR activators. / Visentin, Sonja; Ermondi, Giuseppe; Medana, Claudio; Pedemonte, Nicoletta; Galietta, Luis; Caron, Giulia.

In: European Journal of Medicinal Chemistry, Vol. 55, 09.2012, p. 188-194.

Research output: Contribution to journal › Article

@article{c354169127774572a838763048580da5,

title = "Ligand-based design, in silico ADME-Tox filtering, synthesis and biological evaluation to discover new soluble 1,4-DHP-based CFTR activators",

abstract = "The altered gating of the mutant CFTR chloride channel cystic fibrosis (CF) may be corrected by small molecules called potentiators. We present a molecular scale simulation system for the discovery of ΔF508-CFTR soluble potentiators. Results report the design, ADME-Tox prediction, synthesis, solubility determination and in vitro biological evaluation of two 1,4-dihydropyridines (DHPs). Compound 1 shows a promising ADME-Tox profile and good potency.",

keywords = "3D-QSAR, ADME-Tox, CFTR potentiators, DHP, GRIND, VolSurf+",

author = "Sonja Visentin and Giuseppe Ermondi and Claudio Medana and Nicoletta Pedemonte and Luis Galietta and Giulia Caron",

year = "2012",

month = sep

doi = "10.1016/j.ejmech.2012.07.017",

language = "English",

volume = "55",

pages = "188--194",

journal = "European Journal of Medicinal Chemistry",

issn = "0223-5234",

publisher = "Elsevier Masson SAS",

}

TY - JOUR

T1 - Ligand-based design, in silico ADME-Tox filtering, synthesis and biological evaluation to discover new soluble 1,4-DHP-based CFTR activators

AU - Visentin, Sonja

AU - Ermondi, Giuseppe

AU - Medana, Claudio

AU - Pedemonte, Nicoletta

AU - Galietta, Luis

AU - Caron, Giulia

PY - 2012/9

Y1 - 2012/9

N2 - The altered gating of the mutant CFTR chloride channel cystic fibrosis (CF) may be corrected by small molecules called potentiators. We present a molecular scale simulation system for the discovery of ΔF508-CFTR soluble potentiators. Results report the design, ADME-Tox prediction, synthesis, solubility determination and in vitro biological evaluation of two 1,4-dihydropyridines (DHPs). Compound 1 shows a promising ADME-Tox profile and good potency.

AB - The altered gating of the mutant CFTR chloride channel cystic fibrosis (CF) may be corrected by small molecules called potentiators. We present a molecular scale simulation system for the discovery of ΔF508-CFTR soluble potentiators. Results report the design, ADME-Tox prediction, synthesis, solubility determination and in vitro biological evaluation of two 1,4-dihydropyridines (DHPs). Compound 1 shows a promising ADME-Tox profile and good potency.

KW - 3D-QSAR

KW - ADME-Tox

KW - CFTR potentiators

KW - DHP

KW - GRIND

KW - VolSurf+

UR - http://www.scopus.com/inward/record.url?scp=84865734788&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865734788&partnerID=8YFLogxK

U2 - 10.1016/j.ejmech.2012.07.017

DO - 10.1016/j.ejmech.2012.07.017

M3 - Article

C2 - 22889557

AN - SCOPUS:84865734788

VL - 55

SP - 188

EP - 194

JO - European Journal of Medicinal Chemistry

JF - European Journal of Medicinal Chemistry

SN - 0223-5234

ER -

Access to Document

10.1016/j.ejmech.2012.07.017